* This is a contributed article. The IBTimes news staff was not involved in the creation of this article and this content does not necessarily represent the views of IBTimes. When you buy through links on our site, we may earn an affiliate commission. Here are our T&C. For licensing please click here.
screen glasses
The screen is showing through the glasses. Unsplashed

Within the rapidly evolving realm of artificial intelligence (AI), machine learning (ML) methods are gaining particular attention. The upheaval of 2020 has led companies to prioritize their core objectives, with AI and ML initiatives at the forefront. The ability of machine learning models to generalize and perform complex tasks further fuels their adoption and application across industries. Experts forecast substantial increases in productivity, innovation, growth, and job creation, with some studies predicting labor productivity to increase between 11% and 37% by 2035, thanks to AI and machine learning.

Among the emerging experts in the field is Rohit Dixit, an accomplished machine learning researcher specializing in data science and business intelligence in healthcare. Rohit excels in researching, designing, and implementing data-driven solutions using advanced statistical techniques. One of his notable works is on machine learning on an opioids system, which made a significant impact on healthcare.

Rohit shares his journey of utilizing machine learning to drive advancements in healthcare. He demonstrates how this powerful technology has the potential to revolutionize patient care, optimize workflows, and ultimately save lives.

Machine learning is a relatively new industry, yet you have accomplished quite a lot. Can you share with us how you started in machine learning, specifically in healthcare?

As a Senior Data Scientist at Siemens Healthineers, I specialize in developing machine learning solutions to enhance healthcare and drive analytics within the company. Prior to joining Siemens Healthineers, I held a position as a Data Scientist at Siemens Digital Industries, where I utilized machine learning to improve the software development process and simulation convergence time.

While my current role focuses on applied data science, I consider myself a dedicated researcher at heart. During my graduate studies, I had the opportunity to work as a graduate assistant in the Data Analytics Lab, where I channeled my passion for healthcare. Devoting all my time to the lab, I conducted impactful research that led to significant publications.

You are greatly known for your work on identifying fatal opioid drug interactions using machine learning. Can you tell us more about this project?

Given the widespread challenges associated with opioid consumption, I developed a machine learning system that analyzes opioid data to identify and predict the most fatal drug interactions and their severity. It was remarkable to discover how certain combinations of drugs, when combined with opioids, can significantly impact an individual's chances of survival.

What has been the impact since you developed this system?

The impact of this work is two-fold. Firstly, it aids in enhancing patient safety by informing healthcare providers about the potential dangers of specific drug combinations. From this, they can make more informed decisions when prescribing medications, thus reducing the risks faced by patients.

Secondly, the insights gained from this research contribute to a broader understanding of the opioid crisis, paving the way for targeted interventions and policies that can help address the issue at its core. I am proud to have developed a machine learning system that has the potential to save lives and mitigate the harm caused by opioid misuse.

Your work in healthcare continues to improve and save lives across the country. What other impactful systems have you developed?

I have developed Tyler ADE, a system that uses large volumes of healthcare data and employs severity scoring techniques to predict mortality rates for individuals. The advanced research behind Tyler ADE serves as a crucial early warning system, identifying potential fatalities at an early stage and ultimately saving lives.

I also had work done when the COVID-19 pandemic began and vaccines became available. Using the machine learning system I developed, I was able to examine the data from adverse reaction reports and used that to make data-based decisions about which vaccine would be most suitable for myself, my family, and my friends based on our specific allergies.

The satisfaction of knowing that my work has the potential to improve even one person's well-being serves as a constant driving force for me to continue my endeavors in this field.

What can the industry expect from you in the near future?

I have had the privilege of working on groundbreaking innovations in healthcare research alongside my work on predictive mortality rates. Two patent publications are in the pipeline.

One of these patents focuses on Computer-Aided Design (CAD) for targeted drug delivery systems. This technology allows us to create treatment plans that are tailored to each individual patient. By utilizing CAD, we can model and optimize drug delivery systems specific to a particular drug or patient, ensuring enhanced efficacy and safety in drug administration.

The second patent publication involves the integration of machine learning and the Internet of Things (IoT) for predicting and diagnosing lung cancer. Early detection of lung cancer is vital for improving survival rates, and our system leverages machine learning algorithms and IoT devices to analyze various data sources, such as patient health records, imaging scans, and environmental factors. By accurately predicting and diagnosing lung cancer at an early stage, we can enable timely interventions and treatments.

It is important to emphasize that all of my research work, including the development of these innovative technologies, is independent from my employer. This independence allows me to pursue my passion for advancing scientific knowledge and improving patient care without any conflicts of interest. Furthermore, this ensures the integrity and unbiased nature of my contributions to the field of healthcare analytics.

Final Thought

Rohit Dixit's contribution to healthcare analytics and research, particularly in the subject of opioids, signifies an uplifting development for society at large. By designing and implementing a machine learning system to identify fatal drug interactions and their severity, he has contributed to enhancing patient safety and fostering a deeper understanding of the opioid crisis. As he continues to forge new paths in the field, Rohit Dixit's expertise and dedication position him as a key player in changing healthcare using data-driven solutions.